⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Metrum Research Group and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Metrum Research Group
↗Tariffville, Connecticut, USA
Metrum Research Group is a global leader in biomedical modeling and simulation, providing strategic consulting and project support to pharmaceutical and biotechnology companies. Founded in 2004, the company specializes in pharmacometrics, quantitative systems pharmacology (QSP), and model-informed drug development (MIDD) to optimize drug development programs and support data-driven decision-making.
The company is known for its commitment to open science, maintaining an extensive ecosystem of open-source R packages and tools for the pharmacometrics community. In addition to consulting, they offer 'Metworx,' a cloud-based computation platform designed to help quantitative scientists gain efficiencies in modeling and simulation workflows.
CLASSIFICATION
SIZE & FINANCIALS
Employees:51-200
Revenue:$5M-$50M
Founded:2004
Ownership:private
Status:operating
PIPELINE
Modalities:Small molecule, Biologics, Cell therapy, Gene therapy
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Aplos Analytics (Strategic partnership to integrate Aplos NCA into Metworx platform)
COMPETITION
Position:Leader
Competitors:Certara, Applied BioMath, Parexel, Labcorp
LEADERSHIP
Key Executives:
Michelle Johnson - CEO
Matt Riggs - Chief Science Officer
CJ Godfrey - Vice President of Quantitative Sciences
LINKS
Website:metrumrg.com
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Metrum Research Group. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.